Ichor Holdings, Ltd. designs, engineers, and manufactures critical fluid delivery subsystems and precision components for semiconductor capital equipment. Its core products include gas delivery subsystems and chemical delivery subsystems, which precisely deliver, monitor, and control the specialized gases and reactive chemistries used in semiconductor processes such as etch, deposition, chemical-mechanical planarization, and cleaning. The company also supplies precision-machined components, weldments, and vacuum equipment, and serves adjacent industries including defense, aerospace, and medical.
Headquartered in Fremont, California, ICHR supplies leading wafer fabrication equipment original equipment manufacturers, including Applied Materials and Lam Research, and competes with subsystem suppliers such as Ultra Clean Holdings. Investors follow the stock as a leveraged exposure to wafer fab equipment (WFE) spending and AI-driven semiconductor manufacturing trends. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the trailing 30 days, ICHR declined approximately 38%, falling from a closing price near $61.86 on September 30 to about $38.25. The selloff was not linear: shares initially traded near the low-to-mid $60s in early October before a sharp leg down in mid-October that took the stock into the low $40s, followed by further pressure late in the month.
The 30-day decline is part of a longer downtrend. Over the trailing quarter, ICHR has fallen roughly 49%, down from about $75 at the end of July. The stock reached a 52-week high near $113 in early July before a multi-month correction erased much of its earlier gains, reflecting a substantial valuation reset after a rapid advance.
The recent decline was driven primarily by a broader risk-off rotation across semiconductor and technology names. Rising inflation concerns and higher crude oil prices pressured the Nasdaq and semiconductor equipment complex, with ICHR among the more volatile, higher-beta names caught in the drawdown.
Company-specific caution added to the selling. In mid-October, Oppenheimer highlighted near-term risks to Ichor's supply-chain scaling, and B. Riley lowered its price target to $85 from $105 while maintaining a Buy rating. Earlier in the month, UBS and Freedom Broker issued targets near $82. These revisions, combined with elevated valuation after a steep run, left shares vulnerable to profit-taking. Persistent insider selling has also weighed on sentiment. Public filings have shown a meaningful net outflow of insider sales over the past year, which investors have interpreted as a cautionary signal despite otherwise constructive analyst views.
The quarterly decline reflects a broader reset after an unusually strong advance. ICHR more than doubled from its 52-week low near $14 to a peak above $113 by early July, leaving the stock priced well ahead of near-term fundamentals. Even after its second-quarter report in early August — which included a revenue miss tied to late part shortages but stronger non-GAAP earnings and upbeat guidance — the shares continued to give back gains as valuation multiples contracted.
Investor focus shifted toward execution risks, including customer concentration, flow-control component shortages, and the pace of gross-margin improvement. While management guided for accelerating second-half revenue and margin expansion, the market increasingly questioned how much of the recovery was already reflected in the share price, contributing to the prolonged correction into late October.
The most important near-term catalyst is Ichor's third-quarter 2026 earnings report, scheduled for November 2. Investors will focus on revenue relative to the guided range of $315 million to $345 million, non-GAAP gross margin progress toward the 14.5% to 15.5% target, and management's commentary on the ramp of proprietary content, which was expected to approach 30% exiting the quarter. Beyond earnings, watch supply-chain conditions — particularly flow-control component availability — along with wafer fab equipment spending trends, customer concentration risk, and the trajectory of gross margin toward management's longer-term targets. Macroeconomic factors, including inflation, interest rates, and oil prices, may also continue to influence the broader semiconductor complex and ICHR's trading volatility. One thing that stands out here is how closely the stock tracks broader WFE cycles.
In my own work, I sometimes review Tickeron's Trending AI Robots to see how systematic approaches line up with names like ICHR. The page highlights top-performing bots from a larger library, each with its own strategy and performance metrics, offering a useful reference point alongside fundamental analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ICHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 36 cases where ICHR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 78%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ICHR's RSI Oscillator exited the oversold zone, 23 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 60 cases where ICHR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
Following a +13.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICHR advanced for three days, in 253 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ICHR as a result. In 71 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for ICHR turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 42 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
ICHR moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ICHR crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
The 50-day moving average for ICHR moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ICHR entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.683) is normal, around the industry mean (6.482). P/E Ratio (-33.248) is within average values for comparable stocks, (90.479). Projected Growth (PEG Ratio) (0.251) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.008) among similar stocks. P/S Ratio (1.761) is also within normal values, averaging (27.897).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ICHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company whose subsidiary manufactures gas and chemical delivery systems for semiconductor process equipment
Industry ElectronicProductionEquipment